{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:34:10Z","timestamp":1759941250530,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jcjo.2013.05.018","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T13:01:49Z","timestamp":1386248509000},"page":"524-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["No ocular motility complications after subtenon topotecan with fibrin sealant for retinoblastoma"],"prefix":"10.1016","volume":"48","author":[{"given":"Yacoub A.","family":"Yousef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen S.L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"H\u00e9on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda L.","family":"Gallie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Dimaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2013.05.018_bib1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.2910420408","article-title":"The international incidence of childhood cancer","volume":"42","author":"Parkin","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcjo.2013.05.018_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archopht.123.1.128-b","article-title":"Periocular chemotherapy for retinoblastoma: success with problems?","volume":"123","author":"Abramson","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2013.05.018_bib3","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0161-6420(99)90406-2","article-title":"A phase I\/II study of subconjunctival carboplatin for intraocular retinoblastoma.","volume":"106","author":"Abramson","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2013.05.018_bib4","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1167\/iovs.04-0228","article-title":"Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastoma","volume":"45","author":"Hayden","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2013.05.018_bib5","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.addr.2006.07.025","article-title":"Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling","volume":"58","author":"Ranta","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jcjo.2013.05.018_bib6","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archopht.121.8.1120","article-title":"Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma","volume":"121","author":"Mulvihill","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2013.05.018_bib7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajo.2006.02.044","article-title":"Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma","volume":"142","author":"Schmack","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2013.05.018_bib8","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1158\/1078-0432.CCR-05-0849","article-title":"Topotecan combination chemotherapy in two new rodent models of retinoblastoma","volume":"11","author":"Laurie","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcjo.2013.05.018_bib9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archophthalmol.2011.130","article-title":"Periocular topotecan for intraocular retinoblastoma","volume":"129","author":"Mallipatna","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2013.05.018_bib10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1167\/iovs.07-0653","article-title":"Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma","volume":"49","author":"Tsui","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2013.05.018_bib11","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1200\/JCO.2010.34.3293","article-title":"Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children\u2019s Oncology Group study","volume":"29","author":"Park","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcjo.2013.05.018_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12032-008-9085-8","article-title":"Efficacy of topotecan plus vincristine and doxorubicin in children with recurrent\/refractory rhabdomyosarcoma","volume":"26","author":"Meazza","year":"2009","journal-title":"Med Oncol"},{"key":"10.1016\/j.jcjo.2013.05.018_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/13816810902988780","article-title":"Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation","volume":"30","author":"Dimaras","year":"2009","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.jcjo.2013.05.018_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Linn Murphree","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.jcjo.2013.05.018_bib15","doi-asserted-by":"crossref","unstructured":"Finger P, Harbour JW, Murphree AL, et al. Retinoblastoma. In: Edge SB, Byrd DR, Compton CC, et al. eds. AJCC Cancer Staging Manual, Chapter 52, 7th ed. New York, NY: Springer; 2009; pp. 561-568.","DOI":"10.1007\/978-0-387-88441-7_52"},{"key":"10.1016\/j.jcjo.2013.05.018_bib16","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/archopht.1996.01100140590011","article-title":"Penetration of chemotherapy into vitreous is increased by cryotherapy and cyclosporine in rabbits","volume":"114","author":"Wilson","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2013.05.018_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0168-3659(03)00151-2","article-title":"Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix","volume":"89","author":"Gilbert","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.jcjo.2013.05.018_bib18","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archopht.118.11.1549","article-title":"Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule","volume":"118","author":"Hayden","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2013.05.018_bib19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaapos.2006.11.005","article-title":"Severe pseudo-preseptal cellulitis following sub-Tenon\u2019s carboplatin injection for intraocular retinoblastoma","volume":"11","author":"Kiratli","year":"2007","journal-title":"J AAPOS"},{"key":"10.1016\/j.jcjo.2013.05.018_bib20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00006982-200410000-00015","article-title":"Retinal function after subconjunctival injection of carboplatin in fibrin sealant","volume":"24","author":"Pardue","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2013.05.018_bib21","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1167\/iovs.06-0796","article-title":"Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma","volume":"48","author":"Suarez","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2013.05.018_bib22","first-page":"169","article-title":"The experiment research of subconjunctival injections with etoposide for the treatment of retinoblastoma mice","volume":"21","author":"Mao","year":"2005","journal-title":"Yan Ke Xue Bao"},{"key":"10.1016\/j.jcjo.2013.05.018_bib23","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1167\/iovs.08-2737","article-title":"A phase I study of periocular topotecan in children with intraocular retinoblastoma","volume":"50","author":"Chantada","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2013.05.018_bib24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/bjophthalmol-2011-300517","article-title":"Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity","volume":"96","author":"Marr","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2013.05.018_bib25","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archopht.1997.01100160456013","article-title":"Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma","volume":"115","author":"Murray","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jcjo.2013.05.018_bib26","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1167\/iovs.12-9466","article-title":"Intra-ophthalmic artery chemotherapy triggers vascular toxicity through endothelial cell inflammation and leukostasis","volume":"53","author":"Steinle","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2013.05.018_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2164-9-99","article-title":"Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids","volume":"9","author":"L\u2019Esperance","year":"2008","journal-title":"BMC Genomics"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418213002597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418213002597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:02:55Z","timestamp":1757793775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418213002597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0008418213002597"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2013.05.018","relation":{},"ISSN":["0008-4182"],"issn-type":[{"type":"print","value":"0008-4182"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No ocular motility complications after subtenon topotecan with fibrin sealant for retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2013.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}